Characterization of Lung Hyperresponsiveness, Inflammation, and Alveolar Macrophage Mediator Production in Allergy Resistant and Susceptible Rats
|
|
- Gavin Lawson
- 6 years ago
- Views:
Transcription
1 Characterization of Lung Hyperresponsiveness, Inflammation, and Alveolar Macrophage Mediator Production in Allergy Resistant and Susceptible Rats Eric Careau, Jocelyne Sirois, and Elyse Y. Bissonnette Centre de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l Université Laval, Québec, Canada To better understand asthma pathogenesis, we characterized airway responsiveness, lung inflammation, and mediator production of alveolar macrophages (AM) after allergen sensitization and challenge in two strains of rats showing different susceptibilities in developing airway allergic reactions. Airway responsiveness to acethylcholine was measured 24 h after ovalbumin (OVA) challenge, whereas bronchoalveolar lavages were performed 5 min, 8 h, and 24 h after challenge. Brown Norway rats showed airway hyperresponsiveness after challenge, whereas lung resistance remained unchanged in Sprague- Dawley rats. Interestingly, Sprague-Dawley rats developed a neutrophilic inflammation, whereas both neutrophils and eosinophils were increased in Brown Norway rats. AM mediator production varied with time with a lower tumor necrosis factor (TNF) and interleukin (IL)-10 release at 8 h after challenge. OVA challenge stimulated spontaneous TNF and IL-10 release by AM isolated 24 h after challenge in both strains of rats, although AM from Brown Norway rats released significantly more IL-10 and TNF. Furthermore, nitric oxide production was increased only in OVA-challenged (24 h) Brown Norway rats. Our results suggest that AM may participate to the expansion of Th2 inflammation in Brown Norway rats and that differences in AM mediator production may explain, in part, distinct allergic susceptibilities in these two strains of rats. Asthma is a chronic illness characterized by inflammation, reversible airway obstruction, and increased airway responsiveness to various stimuli (1). There is growing evidence suggesting an important role for T helper (Th)2 cytokine-producing cells in asthma pathogenesis (2). A shift in Th1/Th2 balance has been demonstrated in asthmatic subjects (3) and in ovalbumin (OVA)-sensitized and -challenged Brown Norway rats (4). Although T cells are well known to produce these cytokines and being involved in asthma pathogenesis (5), other cell types may be important in Th2 cytokine production. Furthermore, the cytokine milieu in the lung may play a crucial role in determining the type of primary immune response, Th1 or Th2, to inhaled antigen. Alveolar macrophages (AM) are the most abundant cells in the alveoli, distal airspaces, and conducting airways. They are the first line of defense against infectious agents and other immunologic insults, and one of their functions is to downregulate the immune response in the (Received in original form October 2, 2001 and in revised form January 25, 2002) Address correspondence to: Dr. Elyse Bissonnette, Hôpital Laval 2725, chemin Sainte-Foy, Sainte-Foy, PQ, G1V 4G5 Canada. elyse. bissonnette@med.ulaval.ca Abbreviations: acetylcholine, ACh; alveolar macrophages, AM; bronchoalveolar lavage, BAL; interferon-, IFN- ; immunoglobulin, Ig; interleukin, IL; macrophage inflammatory protein, MIP; nitric oxide, NO; ovalbumin, OVA; phosphate-buffered saline, PBS; pulmonary resistance, RL; T helper, Th; tumor necrosis factor, TNF. Am. J. Respir. Cell Mol. Biol. Vol. 26, pp , 2002 Internet address: lung (6). Depletion of AM in rats with immunologic memory results in a profound state of hyperresponsiveness to inhaled antigens characterized by an increased IgE response and an influx of activated T and B cells into the lung, showing the importance of AM in preventing airway allergic reaction development (7, 8). Interestingly, AM can produce both Th1 (tumor necrosis factor [TNF] and interleukin [IL]-12) and Th2 cytokines (IL-6, IL-10, and IL-13) in addition to a broad range of inflammatory mediators, including nitric oxide (NO), which has been shown to inhibit Th1 response (9 11). Although there is some evidence suggesting that TNF plays an important role in the development of Th1 response (12), TNF has also been shown to increase airway responsiveness in experimental animals and in human subjects, which raises questions as to its role in asthma pathogenesis (13, 14). In asthma, AM are activated (15) and show a decreased inhibitory effect of T cell proliferation (16). Furthermore, they release more proinflammatory cytokines and they enhance IL-5 production by Th cells (17, 18). Thus, AM may participate to create the cytokine milieu, predisposing the development of Th2 cells and promoting allergic inflammation. There is a well-established model of allergen-induced airway hyperresponsiveness in Brown Norway rats (19) that reflects many features of human allergic asthma, including both early and late (70% of animals) phase reactions, increase in antigen-specific IgE following active immunization (20), airway inflammation (21), and increased bronchial responsiveness to several stimuli following allergen challenge (22). In contrast, a low percentage of Sprague- Dawley rats develops an early airway response ( 20%) or detectable serum-specific IgE under the same conditions (23). Furthermore, we have demonstrated for the first time that stimulated AM from naive Sprague-Dawley rats produce significantly more TNF and less IL-10, IL-13, macrophage inflammatory protein (MIP)-1, and NO compared with AM from allergy susceptible Brown Norway rats, suggesting an important role for these cells in the pathogenesis of asthma (10). Using this model, we have investigated AM cytokine production in allergy resistant (Sprague-Dawley) and susceptible (Brown Norway) rats after allergen challenge. Sensitized animals were challenged with aerosolized OVA (5%) for 5 min and AM were isolated 5 min, 8 h, or 24 h later, corresponding to early phase, late phase, and eosinophilic inflammation, respectively (4, 19). Brown Norway rats showed airway hyperresponsiveness to acetylcholine (ACh) after OVA challenge compared with Sprague-Dawley rats, although the latter developed a neutrophilic inflammation. Airway inflammation, measured 24 h after challenge, was higher in Brown Norway rats and their AM released more TNF, IL-10, and NO compared with Sprague-Dawley rats,
2 580 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL suggesting that AM may participate to the distinct allergy susceptibilities observed in these two strains of rats. Materials and Methods Animals Brown Norway rats (BN/Ssn) aged d were obtained from Harlan-Sprague Dawley (Indianapolis, IN) whereas age matched Sprague-Dawley rats were obtained from Charles River (St. Constant, PQ, Canada). All animals were maintained in filter top cages in virus/antigen free conditions in Laval Hospital animal facility on a 12 h light/dark cycle. Animals were given food and water ad libitum. This experimental protocol was approved by University Laval Animal Care Committee in accordance with the guidelines of the Canadian Council on Animal Care. In vivo OVA Sensitization and Challenge Animals were sensitized by intraperitoneal injection of 1 ml OVA grade V (1 mg/ml; Sigma Chemical Co, St. Louis, MO) and Al(OH 3 ) (100 mg/ml; BDH Laboratory Supply, UK) in sterile 0.9% saline solution. Control animals received saline only. Three weeks later, animals were challenged with 5% aerosolized OVA. OVA was aerosolized for 5 min using a Hudson micromist 880 nebulizer (Hudson RCI, Temecula, CA) and an airflow of 6 liters/min air. Control animals were challenged with 0.9% saline solution. Measurement of Airway Responsiveness Measurement of airway hyperresponsiveness was performed with animals that were anesthetized intraperitoneally with an initial dose of 1.5 g/kg urethane (Sigma). Additional urethane was administered as required to maintain adequate anesthesia. Animals were laid on a heating pad and rectal temperature was continuously monitored and maintained between 36 and 38 C. A 6-cm length of PE240 tube (Becton Dickinson Diagnostics, Sparks, MD) was used as endotracheal tube. The end of the intratracheal tube was connected to a Quatra-T CombiChamber (Scireq; Montreal, PQ, Canada), which uses mouth flow and esophageal pressure measurements to accurately calculate pulmonary resistance (R L ). Changes in oesophageal pressure were measured using a saline-filled catheter PE160 (Becton Dickinson) connected to a differential pressure transducer, and mouth flow from intratracheal tube was measured by a pneumotachograph. R L was simultaneously calculated using the software package included with the Quatra-T apparatus. Animals were exposed to aerosolized doubling concentrations of ACh for 30 s and R L measurements were taken every min for 5 min. Peak value of R L was measured after each concentration and the challenge was stopped at 128 mg/ml ACh. The concentration of ACh inducing 200% increase of R L over the initial baseline (EC 200 R L ) was calculated by interpolation of concentration response curve from individual animal. AM Isolation AM were isolated as previously described (10). Cells from bronchoalveolar lavage (BAL) were centrifuged and resuspended in RPMI 1640 medium (Gibco BRL, Burlington, ON, Canada) supplemented with 5% fetal bovine serum (Sigma), penicillin (100 U/ml), streptomycin (100 U/ml) and 10 mm HEPES buffer (Gibco). Purity of AM was determined according to Diff-Quik coloration and nonspecific esterase staining. Minimum of 200 cells/ slide were counted to determine cell type. Viability always exceeded 95% according to Trypan blue exclusion. AM were further purified by adherence. Briefly, AM (10 5 /well) were incubated at 37 C for 2 h and wells were vigorously washed with RPMI 1640 medium, giving a purity of 98%. Cytokines AM were treated with anti-cd8 (OX8; Serotec, Kidlington Oxford, UK), known to stimulate AM cytokine production (10, 24), or isotype control at 5 g/ml for 4 h and 20 h for TNF and IL-10 release, respectively. Cell-free supernatants were tested for TNF and IL-10 content using immunoassay kit for rat TNF and IL-10 (Biosource International, Camarillo, CA) with a sensitivity of 4 pg/ml and 5 pg/ml, respectively. BAL fluids were concentrated 80 times using centrifugal filter devices Centricon PLUS-20 with ultracel PL-10 membranes (Millipore, Nepean, ON, Canada) before measuring TNF and IL-10 levels. Measurement of Nitric Oxide Production After AM treatment (48 h) with OX8 or isotype control at 5 g/ml, cell-free supernatants were assayed for NO 2 using Griess reaction as previously shown (25). NO 2 concentration, propor- tional to OD 540, was determined using a Molecular Device (Menlo Park, CA) V max Kinetic Microplate Reader with reference to a standard curve (NaNO 2 ). Statistical Analysis The hyperresponsiveness data were analyzed using a one-way analysis of variance, whereas data from BAL were analyzed using a two-way analysis of variance. Scheffe s multiple technique was used for a posteriori comparisons. The normality assumption was verified with the Shapiro-Wilk test and the Bartlett s statistic was used to verify the homogeneity of variances for each tested effect. Differences were considered significant when P was The data were analyzed using the statistical package program SAS v8.2 (SAS Institute Inc., Cary, NC). Results Airway Hyperresponsiveness Sensitized Brown Norway and Sprague-Dawley rats were exposed to aerosolized OVA or saline for 5 min and airway reactivity to ACh was measured 24 h later. ACh concentration needed to provoke 200% increase of airway resistance (EC 200 R L ) in saline challenged Sprague-Dawley and Brown Norway rats was mg/ml and mg/ml respectively (Figure 1). OVA challenge did not modulate responsiveness to ACh of Sprague-Dawley rats (64 14 mg/ml). However, airway hyperresponsiveness was significantly higher in OVA challenged Brown Norway rats with an EC 200 R L of mg/ml compared with mg/ml in saline challenged rats. These data demonstrate the development of airway hyperresponsiveness after allergen challenge in OVA-sensitized Brown Norway rats, but not in Sprague-Dawley rats. Airway Inflammation BALs were performed at different times after OVA and saline challenge. Although Brown Norway rats had significantly more cells in BALs than Sprague-Dawley rats, total cell number of each strain of rat did not significantly change after saline challenge (Figure 2). OVA challenge significantly increased number of cells recovered at 24 h in both strains of rats. However, cell recovery was significantly higher in Brown Norway rats ( cells) compared with Sprague-Dawley rats ( cells). Interestingly, OVA challenge caused a significant decrease of cell number in BAL of Brown Norway rats 5 min
3 Careau, Sirois, and Bissonnette: Alveolar Macrophages in Asthma Pathogenesis 581 Figure 1. Concentration of acethylcholine (ACh) required to increase pulmonary resistance (R L ) to 200% of control value (EC 200 R L ). Animals were exposed to ovalbumin (OVA) 21 d after sensitization and ACh airway responsiveness was measured 24 h later. Mean SEM of five animals in each group. Results with different letters are significantly different. and 8 h after allergen challenge, whereas cell number remained unchanged in Sprague-Dawley rats. Saline challenge did not significantly modify cell profile in BAL, although a significant increase in lymphocytes was observed 24 h after saline challenge in both strains of rats (Table 1). An increase in eosinophil was observed at 8 h and 24 h after OVA challenge in Brown Norway rats, and at 24 h only in Sprague-Dawley rats, although the latter had 5.9-fold less eosinophils than Brown Norway rats. Interestingly, neutrophils were significantly increased in both strains of rats at 8 h and 24 h after allergen challenge. However, this increase in neutrophils was significantly higher in Sprague-Dawley rats compared with Brown Norway rats. Number of AM decreased at 5 min and 8 h after OVA challenge in Brown Norway rats and at 8 h in Sprague- Dawley rats, whereas a significant increase was observed at 24 h in both strains of rats (Table 1). Furthermore, there was a 2-fold increase in total number of lymphocytes in bronchoalveolar lavages 24 h after OVA challenge both strains of rats. Figure 2. Total number of cells in bronchoalveolar lavage (BAL) performed at different times after OVA challenge. Saline challenge did not significantly modify cell number but there was significantly ( P 0.01) more cells in BAL of Brown Norway rats compared with the one of Sprague-Dawley rats. There was a significant ( P 0.01) increase of cell number in BAL 24 h after ovalbumin challenge in both strains of rats compared with salinechallenged animals. Significant difference (*P 0.05) between cell number over time within the same strain of rats is indicated by *. Mean SEM of eight experiments. Open bars, 5 min after challenge; striped bars, 8 h after challenge; cross-hatched bars, 24 h after challenge. AM Mediator Production after OVA Sensitization To investigate the immunomodulatory effect of the sensitization protocol on AM mediator production, both strains of rats were sensitized with saline or OVA. Animals were killed 21 d after the sensitization without challenge and AM were purified from BAL. Cells were stimulated with OX8 for 4 h and TNF was measured in cell-free supernatants (Figure 3A). OX8 significantly increased TNF release in both strains of rats. However, stimulated AM from Sprague-Dawley rats released significantly more TNF than AM from Brown Norway rats. Interestingly, OVA sensitization reduced spontaneous and OX8-stimulated TNF release in both Brown Norway and Sprague-Dawley rats. Production of IL-10 was measured in cell-free supernatants of AM stimulated with and without OX8 for 20 h. OX8 significantly increased IL-10 release, but this augmentation was significantly more substantial in Brown Norway rats compared with Sprague-Dawley rats (Figure 3B). OVA sensitization significantly reduced OX8-stimulated IL-10 release by AM in both strains of rats without affecting the spontaneous release. NO production was not modulated by OVA sensitization (Figure 3C). OX8-stimulated AM from Brown Norway rats released significantly more NO than AM from Sprague-Dawley rats. TNF Production by AM Isolated after OVA and Saline Challenge Rats were sensitized with OVA and challenged 21 d later for 5 min with aerosolized saline or OVA. Animals were killed at different times after the challenge (5 min, 8 h, and 24 h) and BAL was performed. AM were purified and stimulated with and without OX8 and levels of TNF in cellfree supernatants were measured. In general, AM from both strains of rats released significantly more TNF after saline challenge compared with unchallenged OVA-sensitized animals (Figures 3A and 4). OX8 significantly increased TNF release by AM from rats challenged with saline and OVA. AM from Sprague-Dawley rats, isolated 5 min and 8 h after saline challenge, released significantly more TNF when stimulated with OX8 than AM from Brown Norway rats (Figures 4A and 4B). Spontaneous release of TNF was not modulated by OVA challenge when cells were isolated 5 min and 8 h after. However, there was a significant increase in spontaneous TNF release when AM were isolated 24 h after OVA challenge (Figure 4C). Interestingly, levels of this cytokine were significantly lower 8 h after challenge compared with 5 min and 24 h. Furthermore, OX8- stimulated AM from Sprague-Dawley rats exposed to saline released significantly more TNF than AM from Brown Norway rats at all times studied (Figure 4). In contrast, OX8-stimulated AM of OVA-challenged Sprague-Dawley rats released a similar amount of TNF and significantly
4 582 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL TABLE 1 Millions of cells in bronchoalveolar lavage of sensitized rats after ovalbumin or saline challenge Time Strain Challenge AM Ly Eo PMN 5 min BN Saline * * OVA * * SD Saline OVA h BN Saline * * OVA * * * SD Saline OVA h BN Saline * * OVA * * * SD Saline OVA Definition of abbreviations: Alveolar macrophages, AM; Brown Norway, BN; eosinophils, Eo; lymphocytes, Ly; neutrophils, PMN; Sprague Dawley, SD. Bronchoalveolar lavage was performed at different times after saline or ovalbumin (OVA) challenge and cells were stained for differential cell counts. * Significant difference (P 0.05) between BN and SD rats. OVA challenge significantly (P 0.05) decreased number of AM at 5 min and 8 h but increased it at 24 h. Number of Eo and PMN significantly increased at 24 h in both strains of rats. AM, Ly, Eo, and PMN number significantly changed over time (P 0.05). Mean SEM of eight animals. less TNF than AM from Brown Norway rats at 5 min and 24 h, respectively (Figure 4). Moreover, AM of OVAchallenged rats released significantly more TNF when stimulated with OX8- compared with saline-challenged animals in both strains of rats after 8 h and 24 h (Figure 4B and 4C). BALs performed 24 h after challenge were concentrated 80 times and TNF levels were measured. There were low levels of TNF in saline-challenged animals ( pg/ml and pg/ml in Brown Norway and Sprague-Dawley rats, respectively, n 4). However, OVA challenge significantly increased TNF levels in BAL of Brown Norway rats ( pg/ml), whereas similar TNF levels were observed in OVA-challenged Sprague-Dawley rats ( pg/ml). Production of IL-10 by AM Isolated after OVA and Saline Challenge AM were isolated after OVA challenge as mentioned above and stimulated with and without OX8 to release IL-10 (Figure 5). OX8 significantly increased AM IL-10 release except in saline-challenged Sprague-Dawley rats and OVA-challenged Brown Norway rats (24 h). OX8- stimulated IL-10 production was significantly higher in Brown Norway rats compared with Sprague-Dawley rats when AM were isolated 5 min and 8 h after saline challenge and 5 min and 24 h after OVA challenge. However, OVA challenge did not modulate AM IL-10 release in Sprague-Dawley rats 5 min after challenge (Figure 5A), but significantly increased both spontaneous and OX8- stimulated IL-10 release from AM of Brown Norway rats. Furthermore, spontaneous IL-10 release 24 h after OVA challenge was significantly increased in both strains of rats compared with 8 h, and this spontaneous release was higher in Brown Norway rats (Figure 5C). Although OVA challenge did not modulate spontaneous release of IL-10 when AM were isolated 8 h after challenge, IL-10 levels were significantly increased 24 h after OVA challenge. IL-10 levels were significantly lower 8 h after challenge compared with 5 min and 24 h, as shown for TNF release. Levels of these cytokines were similar in both strains of rats 8 h after OVA challenge (Figure 5B). IL-10 levels were measured in concentrated BALs performed 24 h after challenge. Similar levels of IL-10 were found in BALs of saline-challenged Brown Norway and Sprague-Dawley rats ( pg/ml and pg/ml respectively, n 4). Although IL-10 levels were not significantly modulated by OVA challenge in Sprague-Dawley rats ( pg/ml), these levels were significantly increased in Brown Norway rats ( pg/ml). NO Production by AM after Challenge AM were isolated at different times after OVA challenge as mentioned above and stimulated with and without OX8 to release NO (Figure 6). OVA challenge significantly increased NO release of OX8-stimulated AM from Brown Norway rats at all time but only after 5 min in Sprague- Dawley rat. OX8-stimulated AM from Brown Norway rats released significantly more NO than AM from Sprague- Dawley rats when isolated after OVA challenge at all times studied. In contrast to IL-10 and TNF release, AM NO production was significantly reduced in all groups of animals killed 24 h after OVA challenge compared with 8 h (Figure 6B and 6C). Furthermore, OVA challenge increased the spontaneous release of NO in both strains of rats at 8 h after the challenge and in Brown Norway rats at 24 h. There was no significant difference in OX8-stimulated AM NO release between saline-challenged Brown Norway and Sprague-Dawley rats at all times studied. Interestingly, our results suggest that AM take more time to produce IL-10 and TNF than NO. Discussion Brown Norway rats have been widely used as a model of asthma and airway hyperresponsiveness using various sensitization protocol (19 22). Although this model has been previously characterized regarding inflammation and airway responsiveness, there are few publications demon-
5 Careau, Sirois, and Bissonnette: Alveolar Macrophages in Asthma Pathogenesis 583 Figure 3. Mediator production by alveolar macrophages (AM) from saline- and OVA-sensitized rats. BAL was performed 21 d after sensitization, and AM were purified and stimulated with OX8 (5 g/ml) for 4, 20, and 48 h for the release of TNF (A), IL-10 (B), and NO (C), respectively. OX8 significantly (*P 0.05) stimulated the release of these mediators compared with sham-treated cells. Significant differences (P 0.05) between Brown Norway (hatched bars) and Sprague-Dawley (open bars) rats within the same treatment (saline or OVA) are indicated by, whereas significant differences (P 0.02) between saline and OVA sensitization within the same strain of rats are indicated by. Mean SEM of eight to ten experiments. Figure 4. TNF production by AM from OVA-sensitized rats challenged with saline or OVA for 5 min. BAL was performed 5 min (A), 8 h (B), or 24 h (C) after challenge, and AM were purified and stimulated with OX8 for the release of TNF compared with sham-treated cells. OX8 significantly (*P 0.05) stimulated the release of this mediator. Significant differences (P 0.05) between Brown Norway (hatched bars) and Sprague-Dawley (open bars) rats within the same treatment (saline or OVA) are indicated by, whereas significant differences (P 0.01) between saline and OVA challenge within the same strain of rats are indicated by. Mean SEM of seven experiments. strating the inflammatory response after allergen challenge in allergic-resistant and -susceptible rats in parallel (26). We have previously demonstrated that AM isolated from naive Brown Norway rats produce more NO and Th2-type cytokines (IL-10 and IL-13) and less Th1-type cytokines (TNF) than AM from Sprague-Dawley rats (10). Furthermore, OVA challenge provokes an early allergic response characterized by defensive posture, opening of the mouth, exaggerated labored breathing motions, and wheezing in OVA-sensitized Brown Norway rats, but not in Sprague- Dawley rats, showing their different susceptibilities to develop allergy. In the present study, we have characterized airway hyperresponsiveness, lung inflammation, and cyto-
6 584 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL Figure 5. IL-10 production by AM from OVA-sensitized rats challenged with saline or OVA for 5 min. BAL was performed 5 min (A), 8 h (B), or 24 h (C) after challenge, and AM were purified and stimulated with OX8 for the release of IL-10. OX8 significantly (*P 0.05) stimulated IL-10 release compared with sham-treated cells. Significant differences (P 0.05) between Brown Norway (hatched bars) and Sprague Dawley (open bars) rats within the same treatment (saline or OVA) are indicated by, whereas significant differences (P 0.01) between saline and OVA challenge within the same strain of rats are indicated by. Mean SEM of seven experiments. Figure 6. NO production by AM from OVA-sensitized rats challenged with saline or OVA for 5 min. BAL was performed 5 min (A), 8 h (B), or 24 h (C) after challenge, and AM were purified and stimulated with OX8 for the release of NO. OX8 significantly (*P 0.05) stimulated NO release compared with shamtreated cells. Significant differences (P 0.05) between Brown Norway (hatched bars) and Sprague-Dawley (open bars) rats within the same treatment (saline or OVA) are indicated by, whereas significant differences (P 0.05) between saline and OVA challenge within the same strain of rats are indicated by. Mean SEM of seven experiments. kine production in these two strains of rats after allergen challenge. OVA-sensitized and -challenged Brown Norway rats showed airway hyperresponsiveness to ACh as demonstrated by other studies (19, 27), but airway responsiveness of Sprague-Dawley rats was not modified by OVA challenge, showing the difference in these two strains of rats with respect to the development of airway hyperresponsiveness. To further understand the resistance of Sprague- Dawley rats to develop allergic asthma, we characterized the inflammatory response after allergen challenge in both strains of rats. To our knowledge, this is the first study demonstrating the modulation of AM functions by intraperitoneal allergen sensitization and the time-course of
7 Careau, Sirois, and Bissonnette: Alveolar Macrophages in Asthma Pathogenesis 585 airway inflammation and cytokine production after allergen challenge in two strains of rats showing different susceptibilities to develop allergic asthma. AM were isolated from saline- and OVA-sensitized rats before allergen challenge to determine the effect of the immunization protocol on mediator production by AM. Interestingly, the allergen sensitization caused a reduction in AM TNF and IL-10 production, whereas NO release was not affected. Local OVA sensitization has been shown to stimulate the production of both IgG and IgE (28). Thus, it is possible that local immunization (intraperitoneally) caused a systemic immune response that may affect AM cytokine production. Although lavage sampling of the airway does not always reflect the milieu of the interstitium, it provides samples that are in close approximation to it (29). Thus, BALs were performed during the early phase (5 min), late phase (8 h), and inflammatory response phase (24 h) after allergen challenge. Interestingly, there were less cells in BAL of Brown Norway rats 5 min and 8 h after OVA challenge compared with saline challenge. It is possible that the bronchoconstriction observed during the early and late phase in Brown Norway rats, but not in Sprague-Dawley rats, reduced cell recovery in BAL of these rats. However, both strains of rats showed an inflammatory response 24 h after allergen challenge, although the inflammation was significantly higher in Brown Norway rats compared with Sprague- Dawley rats. The characterization of the inflammatory responses 24 h after OVA challenge showed interesting differences between the two strains of rats. Brown Norway rats showed a neutrophilic and eosinophilic inflammation (27), whereas Sprague-Dawley rats had an important neutrophilic but a limited eosinophilic inflammation. Furthermore, there was a similar increase in number of lymphocytes in both strains of rats but there was a significant increase of AM in Brown Norway rats only. Thus, the difference in the susceptibilities of these two strains of rats to develop allergic asthma may depend on the intensity of the inflammatory response in the lung as well as the cell types involved in this inflammation. Production of mediators by AM may play an important role in asthma pathogenesis (7). AM TNF production varies over time with a minimum production 8 h after challenge, but there was a significant increase in AM TNF release in both strains of rats 24 h after OVA challenge. In general, Sprague-Dawley rats produce more TNF than Brown Norway rats except at 24 h after OVA challenge, suggesting a protective role early in time. The role of TNF as a protective or potentiating mediator in asthma is controversial (12 14). Our data suggest that the timing of TNF production may be important in the inflammatory process to determine which type of inflammatory response, Th1 or Th2, will take place. However, TNF seems to be involved during the allergic inflammatory response (24 h) as measured in BAL fluids. The complexity of TNF effects on lung functions has already been suggested by Martin and coworkers (30). IL-10 production was reduced 8 h after challenge, but no difference was observed in OVA-challenged animals at that time. However, at 5 min and 24 h after challenge, stimulated AM from Brown Norway rats produced more IL-10 than AM from Sprague-Dawley rats. OVA challenge (24 h) stimulated AM spontaneous release of IL-10 release in both strains of rats, although the increase was significantly stronger in Brown Norway rats compared with Sprague-Dawley rats. Higher IL-10 production observed in Brown Norway rats may potentiate the Th2-type response by donwregulating interferon- (IFN- ) and IL-12 production (26, 31 32). Increased exhaled NO has been demonstrated after challenge in sensitized animals (33). Furthermore, exhaled NO is increased in patients with asthma, and there is a strong correlation between NO levels and airway hyperresponsiveness (34). NO production by stimulated AM decreased with time after challenge in our model. However, OX8-stimulated AM from Brown Norway rats released significantly more NO than AM from Sprague-Dawley rats at all times investigated. In vivo OVA challenge stimulated the spontaneous release of NO from AM of Brown Norway rats at 8 h and 24 h, but not of Sprague-Dawley rats, compared with saline-challenged animals, suggesting that AM NO production may play an important role in the development of allergic asthma. This increase in AM NO production may contribute to the inhibition of Th1 response, as previously suggested (35). The production of Th2 cytokines after antigen challenge of sensitized rats has been previously shown (4, 26). An increase of IL-4 and IL-5 mrna levels in the lung has been observed in Brown Norway rats after OVA challenge, whereas increase in IL-2 and IFN- mrna levels has been observed in Sprague-Dawley rats (26). However, protein levels have not been investigated. Furthermore, to our knowledge, mediator production by AM at different times after allergen challenge has never been demonstrated. Our results suggest that AM may participate to the expansion of Th2 inflammation in Brown Norway rats. Differences in mediator production by AM of Brown Norway and Sprague-Dawley rats may play an important role in the development of airway inflammation. Furthermore, AM of Sprague-Dawley rats may protect the animal against the development of allergic asthma, as previously suggested (7, 8). However, further investigations are needed to better understand the importance of AM in the development of airway responsiveness. Acknowledgments: The authors thank Geneviève Ménard for her technical support and Dr. Jamila Chakir for critical reading of the manuscript. This work was supported by the Medical Research Council of Canada and the Réseau en Santé Respiratoire du FRSQ-axe asthme. E.Y.B. is a senior FRSQ Scholar. References 1. Goldstein, R. A., W. E. Paul, D. D. Metcalfe, W. W. Busse, and E. R. Reece NIH conference: asthma. Ann. Intern. Med. 121: Le Gros, G., K. Erb, N. Harris, J. Holloway, K. McCoy, and F. Ronchese Immunoregulatory networks in asthma. Clin. Exp. Allergy 28: Paul, W Determination of the lymphokine-producing phenotype of CD4 T cells: a potential control point in allergic and infectious diseases. Ann. Intern. Med. 121: Romagnani, S Regulation of the development of type 2 T-helper cells in allergy. Curr. Opin. Immunol. 6: Corrigan, C. J., and A. B. Kay T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13: Schauble, T. L., W. H. Boom, C. K. Finegan, and E. A. Rich Characterization of suppressor function of human alveolar macrophages for T lymphocyte responses to phyto-hemagglutinin: cellular selectivity, reversibility, and early events in T cell activation. Am. J. Respir. Cell Mol. Biol. 8:
8 586 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL Strickland, D. H., T. Thepen, U. R. Kees, G. Kraal, and P. G. Holt Regulation of T-cell function in lung tissue by pulmonary alveolar macrophages. Immunology 80: Thepen, T., C. McMenamin, B. Girn, G. Kraal, and P. G. Holt Regulation of IgE production in presensitised animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen. Clin. Exp. Allergy 22: Mills, C. D., K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill M-1/ M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164: Sirois, J., and E. Y. Bissonnette Alveolar macrophages of allergic resistant and susceptible strains of rats show distinct cytokine profiles. Clin. Exp. Immunol. 126: Taylor-Robinson, A. W., F. Y. Liew, A. Severn, D. Xu, S. J. McSorley, P. Garside, J. Padron, and R. S. Phillips Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24: Becher, B., M. Blain, P. S. Giacomini, and J. P. Antel Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J. Immunol. 162: Kips, J. C., J. Tavernier, and R. A. Pauwels Tumor necrosis factor (TNF) causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145: Thomas, P. S., D. H. Yates, and P. J. Barnes Tumor necrosis factor- increases airway responsiveness and sputum neutrophilia in normal human subjects. Am. J. Respir. Crit. Care Med. 152: Oosterhoff, Y., H. C. Hoogsteden, B. Rutgers, H. F. Kauffman, and D. S. Postma Lymphocyte and macrophage activation in bronchoalveolar lavage fluid in nocturnal asthma. Am. J. Respir. Crit. Care Med. 151: Aubas, P., B. Cosso, P. Godard, F. B. Michel, and J. Clot Decreased suppressor cell activity of alveolar macrophages in bronchial asthma. Am. Rev. Respir. Dis. 130: John, M., S. Lim, J. Seybold, P. Jose, A. Robichaud, B. O Connor, P. J. Barnes, and K. F. Chung Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1, granulocyte-macrophage colony-stimulating factor, and interferon- release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med. 157: Tang, C., J. M. Rolland, X. Li, C. Ward, R. Bish, and E. H. Walters Alveolar macrophages from atopic asthmatics, but not atopic nonasthmatics, enhance interleukin-5 production by CD4 T cells. Am. J. Respir. Crit. Care Med. 157: Elwood, W., J. O. Lötvall, P. J. Barnes, and K. F. Chung Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown Norway rats. J. Allergy Clin. Immunol. 88: Waserman, S., R. Olivenstein, P. M. Renzi, L. J. Xu, and J. G. Martin The relationship between late asthmatic responses and antigen-specific immunoglobulin. J. Allergy Clin. Immunol. 90: Renzi, P. M., R. Olivenstein, and J. G. Martin Inflammatory cell populations in the airways and parenchyma after antigen challenge in the rat. Am. Rev. Respir. Dis. 147: Bellofiore, S., and J. G. Martin Antigen challenge of sensitised rats increases airway responsiveness to methacholine. J. Appl. Physiol. 65: Olivenstein, R., P. M. Renzi, J. P. Yang, P. Rossi, S. Laberge, S. Waserman, and J. G. Martin Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats. J. Clin. Invest. 92: Lin, T. J., N. Hirji, G. R. Stenton, M. Gilchrist, B. J. Grill, A. D. Schreiber, and A. D. Befus Activation of macrophage CD8: pharmacological studies of TNF and IL-1 beta production. J. Immunol. 164: Bissonnette, E. Y., C. M. Hogaboam, J. L. Wallace, and A. D. Befus Potentiation of TNF- mediated cytotoxicity of mast cells by their production of nitric oxide. J. Immunol. 147: Renzi, P. M., A. S. al Assaad, J. Yang, Z. Yasruel, and Q. Hamid Cytokine expression in the presence or absence of late airway responses after antigen challenge of sensitized rats. Am. J. Respir. Cell Mol. Biol. 15: Haczku, A., J. Sun, K. F. Chung, P. J. Barnes, A. B. Kay, and R. Moqbel Airway hyperresponsiveness, elevation of serum-specific IgE and activation of T cells following allergen exposure in sensitized Brown-Norway rats. Immunology 85: Waserman, S., R. Olivenstein, P. Renzi, L. J. Xu, and J. G. Martin The relationship between late asthmatic responses and antigen-specific immunoglobulin. J. Allergy Clin. Immunol. 90: Reynolds, H. Y Use of bronchoalveolar lavage in humans past necessity and future imperative. Lung 178: Martin, C., A. Wohlsen, and S. Uhlig Changes in airway resistance by simultaneous exposure to TNF-alpha and IL-1beta in perfused rat lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O Garra IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146: D Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri Interleukin 10 (IL-10) inhibits human lymphocyte interferon -production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J. Exp. Med. 178: Persson, M. G., and L. E. Gustafsson Allergen-induced airway obstruction in guinea-pigs is associated with change in nitric oxide levels in exhaled air. Acta Physiol. Scand. 149: Xiong, Y., G. Karupiah, S. P. Hogan, P. S. Foster, and A. J. Ramsay Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J. Immunol. 162: Yan, Z. Q., G. K. Hansson, B. E. Skoogh, and J. O. Lötvall Induction of nitric oxide synthase in a model of allergic occupational asthma. Allergy 50:
Abstract. IgE. IgE Th2. x x IL-4 IL-5 IgE CD4 +
D. o ƒf 6,''!" # + % %$ '& ' '' & " k n k x k k k k k x k IgE k x IgE Ò1Ó k Ò2Ó v k x IgE Th2 x } x x IL-4 IL-5 IgE IgE j IFN-γ IgG j j CD4 + { k d «d j B7 w k k x IgE k 1 k Abstract Parental immunization
More informationAlveolar macrophages modulate allergic inflammation in a murine model of asthma
EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 43, No. 5, 275-280, May 2011 Alveolar macrophages modulate allergic inflammation in a murine model of asthma Bo-Ram Bang 1,2, Eunyoung Chun 1,2, Eun-Jin Shim 1,2,
More informationImmunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline! Consensus characteristics! Allergens:role in asthma! Immune/inflammatory basis! Genetic basis!
More informationOrganic dust-induced interleukin-12 production activates T- and natural killer cells
Eur Respir J 22; 2: 686 69 DOI:.1183/931936.2.222 Printed in UK all rights reserved Copyright #ERS Journals Ltd 22 European Respiratory Journal ISSN 93-1936 Organic dust-induced interleukin-12 production
More informationImpact of Asthma in the U.S. per Year. Asthma Epidemiology and Pathophysiology. Risk Factors for Asthma. Childhood Asthma Costs of Asthma
American Association for Respiratory Care Asthma Educator Certification Prep Course Asthma Epidemiology and Pathophysiology Robert C. Cohn, MD, FAARC MetroHealth Medical Center Cleveland, OH Impact of
More informationE-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling
E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling Ruby Pawankar, MD, Ph.D. FRCP, FAAAAI Prof. Div of Allergy, Dept of Pediatrics Nippon Medical School Tokyo, Japan pawankar.ruby@gmail.com
More informationAllergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.
Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 75: Approach to Infants and Children with Asthma
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More information10.00 PBS OVA OVA+isotype antibody 8.00 OVA+anti-HMGB1. PBS Methatroline (mg/ml)
RESEARCH ARTICLE Penh (100% of PBS) 1 PBS 8.00 +anti-hmgb1 6.00 4.00 p=0.054 Cellular & Molecular Immunology advance online publication, PBS 3.12 6.25 Methatroline (mg/ml) Neutrophil isolation and culture
More informationInducible Nitric Oxide Synthase mrna and Immunoreactivity in the Lungs of Rats Eight Hours after Antigen Challenge
Inducible Nitric Oxide Synthase mrna and Immunoreactivity in the Lungs of Rats Eight Hours after Antigen Challenge Paolo M. Renzi, Noami Sebastiao, Ali S. Al Assaad, Adel Giaid, and Qutayba Hamid Department
More informationMonitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study
Eur Respir J 2010; 35: 48 53 DOI: 10.1183/09031936.00130008 CopyrightßERS Journals Ltd 2010 Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study J. Chakir*, L. Loubaki*,
More informationSystems Pharmacology Respiratory Pharmacology. Lecture series : General outline
Systems Pharmacology 3320 2017 Respiratory Pharmacology Associate Professor Peter Henry (Rm 1.34) Peter.Henry@uwa.edu.au Division of Pharmacology, School of Biomedical Sciences Lecture series : General
More informationAsthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management
Asthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management Eugene R. Bleecker, MD Professor and Director, Center for Genomics & Personalized Medicine Research Professor, Translational
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More informationDefining Asthma: Bronchial Hyperresponsiveness. Defining Asthma: Clinical Criteria. Impaired Ventilation in Asthma. Dynamic Imaging of Asthma
Defining Asthma: Clinical Criteria Defining Asthma: Bronchial Hyperresponsiveness Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine,
More informationB220 CD4 CD8. Figure 1. Confocal Image of Sensitized HLN. Representative image of a sensitized HLN
B220 CD4 CD8 Natarajan et al., unpublished data Figure 1. Confocal Image of Sensitized HLN. Representative image of a sensitized HLN showing B cell follicles and T cell areas. 20 µm thick. Image of magnification
More informationModulation of hyperresponsiveness by glutathione in a murine in vivo model of allergic asthma
6 Modulation of hyperresponsiveness by glutathione in a murine in vivo model of allergic asthma J. Kloek, I. Van Ark, G. Folkerts, F. De Clerck,, N. Bloksma,, F.P. Nijkamp. Department of Pharmacology and
More informationChemical Chaperones Mitigate Experimental Asthma By Attenuating Endoplasmic
Chemical Chaperones Mitigate Experimental Asthma By Attenuating Endoplasmic Reticulum Stress Lokesh Makhija, BE, Veda Krishnan, MSc, Rakhshinda Rehman, MTech, Samarpana Chakraborty, MSc, Shuvadeep Maity,
More informationIdentifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations
Identifying Biologic Targets to Attenuate or Eliminate Exacerbations exacerbations are a major cause of disease morbidity and costs. For both children and adults, viral respiratory infections are the major
More information감초 (Glycyrrhiza uralensis Fisch, GLU) 가천식모델생쥐의 BALF 내면역세포및 Cytokine 에미치는효과
감초 (Glycyrrhiza uralensis Fisch, GLU) 가천식모델생쥐의 BALF 내면역세포및 Cytokine 에미치는효과 Effects of Glycyrrhiza uralensis Fisch on Immunocyte and Cytokine Production in Asthma Model Mouse Young-Joo Han, Yang-Chun Park
More informationBronchial asthma is a chronic inflammatory disorder
Increased Expression of the Chemoattractant Cytokines Eotaxin, Monocyte Chemotactic Protein-4, and Interleukin-16 in Induced Sputum in Asthmatic Patients* Rame A. Taha, MD; Sophie Laberge, MD; Qutayba
More informationACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT
ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes
More informationCOPYRIGHTED MATERIAL. Definition and Pathology CHAPTER 1. John Rees
CHAPTER 1 Definition and Pathology John Rees Sherman Education Centre, Guy s Hospital, London, UK OVERVIEW Asthma is an overall descriptive term but there are a number of more or less distinct phenotypes
More informationProperty of Presenter
Have We Missed A Role For Neutrophils In Asthma? In Steroid-Refractory Asthma? Erwin W. Gelfand, MD Chairman, Department of Pediatrics National Jewish Health Professor of Pediatrics and Immunology University
More informationAirway Inflammation in Asthma Chih-Yung Chiu 1,2, Kin-Sun Wong 2 1 Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan.
REVIEW ARTICLE Chih-Yung Chiu 1,2, Kin-Sun Wong 2 1 Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan. 2 Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Memorial
More informationOriginal Article Serum Levels of IL-17A Increase in Asthma But Don t Correlate with Serum Level of IgE and Asthma Severity
International Journal of Medical Laboratory 2015;2(1):25-33. Original Article Serum Levels of IL-17A Increase in Asthma But Don t Correlate with Serum Level of IgE and Asthma Severity Masouma Mowahedi
More informationMedicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air
Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air through the airways. As asthma, COPD ( chronic bronchitis
More informationIgE-mediated allergy in elderly patients with asthma
Allergology international (1997) 46: 237-241 Original Article IgE-mediated allergy in elderly patients with asthma Fumihiro Mitsunobu, Takashi Mifune, Yasuhiro Hosaki, Kouzou Ashida, Hirofumi Tsugeno,
More informationMouse Anti-OVA IgM Antibody Assay Kit
Mouse Anti-OVA IgM Antibody Assay Kit Catalog # 3017 For Research Use Only - Not Human or Therapeutic Use INTRODUCTION Ovalbumin (OVA) is a widely used antigen for inducing allergic reactions in experimental
More informationMETHODS. participated in the study. Each subject had a normal physical examination, chest
METHODS Subjects Thirty-four subjects (20 men and 14 women, mean age 28.5 ± 1.2 yr) participated in the study. Each subject had a normal physical examination, chest radiograph, electrocardiogram, and laboratory
More informationRole of Tyk-2 in Th9 and Th17 cells in allergic asthma
Supplementary File Role of Tyk-2 in Th9 and Th17 cells in allergic asthma Caroline Übel 1*, Anna Graser 1*, Sonja Koch 1, Ralf J. Rieker 2, Hans A. Lehr 3, Mathias Müller 4 and Susetta Finotto 1** 1 Laboratory
More informationPhenotypes of asthma; implications for treatment. Medical Grand Rounds Feb 2018 Jim Martin MD DSc
Phenotypes of asthma; implications for treatment Medical Grand Rounds Feb 2018 Jim Martin MD DSc No conflicts to declare Objectives To understand the varied clinical forms of asthma To understand the pathobiologic
More informationIL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy
Eur Respir J, 1997; 1: 624 632 DOI: 1.1183/931936.97.13624 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 93-1936 IL-5 production by bronchoalveolar
More informationNovel biomarkers of chemical-induced asthma: a murine model. Jeroen Vanoirbeek
Novel biomarkers of chemical-induced asthma: a murine model Jeroen Vanoirbeek Asthma 1. Chronic airway disease: prevalence: 5-10%, 300.000 people affected world-wide 2. Reversible airflow limitation, airway
More informationSignaling through Fc RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation
Signaling through Fc RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation Hozefa S. Bandukwala, 1 Bryan S. Clay, 1 Jiankun Tong, 2 Purvi D. Mody, 1 Judy L. Cannon,
More informationMedical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More informationClinical significance of airway inflammation in bronchcial asthma. Comparison with chronic obstructive bronchiolitis.
24 Airway inflammation in asthma Clinical significance of airway inflammation in bronchcial asthma. Comparison with chronic obstructive bronchiolitis. Yoshiro Tanizaki, Hikaru Kitani, Takashi Mifune, Fumihiro
More informationUsing Patient Characteristics to Individualize and Improve Asthma Care
Using Patient Characteristics to Individualize and Improve Asthma Care Leonard B. Bacharier, M.D. Associate Professor of Pediatrics Clinical Director, Division of Allergy, Immunology, & Pulmonary Medicine
More informationUnderstanding How Allergic Responses End: The Allergy Resolvome. Lipid mediators
Understanding How Allergic Responses End: The Allergy Resolvome Lipid mediators Koichiro Asano Tokai University School of Medicine, Kanagawa, JAPAN ko-asano@tokai-u.jp Resolution of granulocytic inflammation
More informationTh2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4
Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4 Christina A. Herrick, 1,2 Heather MacLeod, 2 Earl Glusac, 1,3 Robert E. Tigelaar, 1,2 and Kim
More informationCurrent Asthma Therapy: Little Need to Phenotype. Phenotypes of Severe Asthma. Cellular Phenotypes 12/7/2012
Subbasement Membrane Thickness(µm) 12/7/212 Current Asthma Therapy: Little Need to Phenotype Phenotypes of Severe Asthma Most mild and to some degree moderate asthmatics respond well to currently available
More informationDNA vaccine, peripheral T-cell tolerance modulation 185
Subject Index Airway hyperresponsiveness (AHR) animal models 41 43 asthma inhibition 45 overview 41 mast cell modulation of T-cells 62 64 respiratory tolerance 40, 41 Tregs inhibition role 44 respiratory
More informationDiagnosis and Management of Fungal Allergy Monday, 9-139
Diagnosis and Management of Fungal Allergy Monday, 9-139 13-2010 Alan P. Knutsen,, MD Director, Pediatric Allergy & Immunology Director, Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies
More informationSupplementary Information
Supplementary Information TABLE S1. SUBJECT CHARACTERISTICS* Normal Control Subjects Subjects with Asthma p Value Number 23 48 Age (years) 35±10 35±10 0.75 Sex, M:F (% F) 9:12 (57) 17:26 (60) 0.76 FEV1
More informationExhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma
Exhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma Jason Debley, MD, MPH Assistant Professor, Pediatrics Division of Pulmonary Medicine University of Washington School of
More informationImmunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline Consensus characteristics/incidence data Immune/inflammatory basis Etiology/Genetic basis Hygiene
More informationSERIES 'OCCUPATIONAL ASTHMA' Edited by C. Mapp
Eur Respir J, 1994, 7, 555 568 DOI: 10.1183/09031936.94.07030555 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1994 European Respiratory Journal ISSN 0903-1936 SERIES 'OCCUPATIONAL ASTHMA'
More informationImmunology lecture: 14. Cytokines: Main source: Fibroblast, but actually it can be produced by other types of cells
Immunology lecture: 14 Cytokines: 1)Interferons"IFN" : 2 types Type 1 : IFN-Alpha : Main source: Macrophages IFN-Beta: Main source: Fibroblast, but actually it can be produced by other types of cells **There
More informationBiomerker onderzoek voor isocyanaatgeïnduceerd
CGC en NVAB meeting, 6 Juni 2013, s-hertogenbosch Biomerker onderzoek voor isocyanaatgeïnduceerd astma Jeroen Vanoirbeek Asthma 1. Chronic airway disease: prevalence: 5-10%, 300.000 people affected world-wide
More informationSystems Pharmacology Respiratory Pharmacology. Lecture series : General outline
Systems Pharmacology 3320 2017 Respiratory Pharmacology Associate Professor Peter Henry (Rm 1.34) Peter.Henry@uwa.edu.au Division of Pharmacology, School of Biomedical Sciences Lecture series : General
More informationASTHMA TREATMENT EFFICACY ASSESSMENT BY FeNO MEASUREMENT
Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 5 (54) No. 2-2012 ASTHMA TREATMENT EFFICACY ASSESSMENT BY FeNO MEASUREMENT Dana ALEXANDRESCU 1 Abstract: The author of
More informationWhat differentiates respiratory sensitizers from skin sensitizers?
What differentiates respiratory sensitizers from skin sensitizers? Implications for predictive toxicity testing Janine Ezendam Janine.Ezendam@rivm.nl 1 Background GHS classification and labeling of chemicals:
More informationClinical Benefits of FeNO Monitoring in Asthma RYAN BURTON, MS, RPFT
Clinical Benefits of FeNO Monitoring in Asthma RYAN BURTON, MS, RPFT Disclosures I am an employee of Circassia Pharmaceuticals. Objectives Nitric Oxide Inflammation in Asthma Phenotyping Personalized Medicine
More informationGSI Canine IL-5 ELISA Kit-2 Plates DataSheet
Interleukin5 (IL5) is a secreted glycoprotein that belongs to the α-helical group of cytokines (1, 2, 3). Unlike other family members, it is present as a covalently linked antiparallel dimer (4, 5). IL-5
More informationIncreased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation
Eur Respir J 998; : 5655 DOI:.83/93936.98.356 Printed in UK - all rights reserved Copyright ERS Journals Ltd 998 European Respiratory Journal ISSN 93-936 Increased peak expiratory flow variation in asthma:
More informationChapter 23 Immunity Exam Study Questions
Chapter 23 Immunity Exam Study Questions 1. Define 1) Immunity 2) Neutrophils 3) Macrophage 4) Epitopes 5) Interferon 6) Complement system 7) Histamine 8) Mast cells 9) Antigen 10) Antigens receptors 11)
More informationRobert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network
Robert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network Robert.kruklitis@lvh.com Correlation of a Asthma pathophyisology with basic science Asthma (Physiology) Bronchodilators
More informationRole of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response
Research article Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response Tao Peng, 1 Liming Hao, 2 Joseph A. Madri, 2 Xiao Su, 1 Jack A. Elias, 3 Gregory
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: exhaled_nitric_oxide_measurement 2/2009 3/2018 3/2019 3/2018 Description of Procedure or Service Asthma is
More informationPotent and Selective CRTh2 Antagonists are Efficacious in Models of Asthma, Allergic Rhinitis and Atopic Dermatitis
Potent and Selective CRTh2 Antagonists are Efficacious in Models of Asthma, Allergic Rhinitis and Atopic Dermatitis Laura L. Carter, Yoshi Shiraishi, Yooseob Shin, Laurence Burgess, Christine Eberhardt,
More informationcolorimetric sandwich ELISA kit datasheet
colorimetric sandwich ELISA kit datasheet For the quantitative detection of human TNF-alpha in serum, plasma and cell culture supernatants. general information Catalogue Number Product Name Species cross-reactivity
More informationAge-related changes of IgE-mediated allergic reaction in patients with late onset asthma.
50 Changes in IgE-mediated allergic reaction with aglllg Age-related changes of IgE-mediated allergic reaction in patients with late onset asthma. Fumihiro Mitsunobu, Takashi Mifune, Yasuhiro Hosaki, Kouzou
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationDr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline
Pathology of Asthma Dr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline Bronchial Asthma Definition: chronic, relapsing inflammatory lung disorder characterised by reversible
More informationAsthma. Rachel Miller, MD, FAAAAI Director Allergy and Immunology New York Presbyterian Hospital. Figure 1 Asthma Prevalence,
Asthma Rachel Miller, MD, FAAAAI Director Allergy and Immunology New York Presbyterian Hospital Figure 1 Asthma Prevalence, 1980-2000 * Gap between 1995-1996 and 1997 indicates a break in trend due to
More informationSupplementary Figures
Inhibition of Pulmonary Anti Bacterial Defense by IFN γ During Recovery from Influenza Infection By Keer Sun and Dennis W. Metzger Supplementary Figures d a Ly6G Percentage survival f 1 75 5 1 25 1 5 1
More informationMechanisms of action of bronchial provocation testing
Mechanisms of action of bronchial provocation testing TSANZ / ANZSRS Masterclass: April 3rd, 2016 13:00 13:30 John D. Brannan PhD Scientific Director - Dept. Respiratory & Sleep Medicine John Hunter Hospital,
More informationExhaled Biomarkers Asthma & COPD. AS Paul DM Seminar 30 March 07
Exhaled Biomarkers Asthma & COPD AS Paul DM Seminar 30 March 07 Introduction Diagnosis and course of COPD/Asthma Clinical information Pulmonary function tests Arterial blood gases Chest X-raysX No direct
More informationILC2 Cells in the Holsapple Laboratory CRIS Annual Meeting
ILC2 Cells in the Holsapple Laboratory 2016 CRIS Annual Meeting ILC2 Characteristics in Humans o Non-cytotoxic, classic lymphoid morphology but lacking lineage markers o Primarily found in gut, lung, and
More informationOriginal Article CD4 + T cell proliferation and inhibition of activation-induced cell death (AICD) in childhood asthma
Int J Clin Exp Med 2018;11(3):2319-2324 www.ijcem.com /ISSN:1940-5901/IJCEM0066213 Original Article CD4 + T cell proliferation and inhibition of activation-induced cell death (AICD) in childhood asthma
More informationMouse Total IgA Antibody Detection Kit
Mouse Total IgA Antibody Detection Kit Catalog # 3019 For Research Use Only - Not Human or Therapeutic Use INTRODUCTION The total IgA levels in specimens are often determined in mouse disease models involving
More informationThe Effect of BTP on the Development of Allergic Asthma in Mice
93 The Effect of BTP on the Development of Allergic Asthma in Mice Alana Curry, McNair Scholar, Virginia State University Faculty Advisor: Avery August, Ph.D Associate Professor of Immunology Department
More informationCopyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and
Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationCOPD and Asthma: Similarities and differences Prof. Peter Barnes
and Asthma: Similarities and Differences and Asthma: 1 Imperial College Peter Barnes FRS, FMedSci, National Heart & Lung Institute Imperial College, London, UK p.j.barnes@imperial.ac.uk Royal Brompton
More informationEffector T Cells and
1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New
More informationBasis of Immunology and
Basis of Immunology and Immunophysiopathology of Infectious Diseases Jointly organized by Institut Pasteur in Ho Chi Minh City and Institut Pasteur with kind support from ANRS & Université Pierre et Marie
More informationChronic Cough Due to Nonasthmatic Eosinophilic Bronchitis. ACCP Evidence-Based Clinical Practice Guidelines
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis ACCP Evidence-Based Clinical Practice Guidelines Christopher E. Brightling, MBBS, PhD, FCCP Objectives: Nonasthmatic eosinophilic bronchitis is
More informationTheophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics
Eur Respir J 1999; 13: 53±58 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 Theophylline induces a reduction in circulating interleukin-4
More informationBead Based Assays for Cytokine Detection
Bead Based Assays for Cytokine Detection September 27, 2014 6 th EFIS-EJI South East European Immunology School SEEIS 2014 Timisoara, Romania The Cells of the Immune System The Immune Reaction (Th2) (Th1)
More informationNeonatal Exposure to Microbial Phosphorylcholine Modulates the Development of House Dust Mite Allergy During Adult Life
Neonatal Exposure to Microbial Phosphorylcholine Modulates the Development of House Dust Mite Allergy During Adult Life J. Sides SEM Preeyam Patel Mentor: Dr John Kearney 015 CAMBAC Research Day 9/18/15
More informationClinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy
Clinical Implications of Asthma Phenotypes Michael Schatz, MD, MS Department of Allergy Definition of Phenotype The observable properties of an organism that are produced by the interaction of the genotype
More informationState of Science for Respiratory Sensitization
State of Science for Respiratory Sensitization Dose-Response Models for the OEL-Derivation of Chemicals Jürgen Pauluhn Global Drug Discovery, Bayer HealthCare, Bayer Pharma AG, Wuppertal, Germany Hannover
More informationValidation of the Efficacy of a Practical Method for Neutrophils Isolation from Peripheral Blood
Validation of the Efficacy of a Practical Method for Neutrophils Isolation from Peripheral Blood JONATHAN DEGEL, MASIH SHOKRANI OBJECTIVE: The objectives of this study were to validate the Polymorphprep
More informationInhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Eur Respir J 21; 18: 635 639 Printed in UK all rights reserved Copyright #ERS Journals Ltd 21 European Respiratory Journal ISSN 93-1936 Inhaled fluticasone decreases bronchial but not alveolar nitric oxide
More informationSearching for Targets to Control Asthma
Searching for Targets to Control Asthma Timothy Craig Distinguished Educator Professor Medicine and Pediatrics Penn State University Hershey, PA, USA Inflammation and Remodeling in Asthma The most important
More informationAsthma is a major chronic respiratory. Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells
Eur Respir J 11; 7: DOI: 1.11/919.91 CopyrightßERS 11 Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells J.A. Preston*,, A.N. Thorburn*,, M.R. Starkey*,
More informationProtocols for the Induction and Evaluation of Systemic Anaphylaxis in Mice
Chapter 10 Protocols for the Induction and Evaluation of Systemic Anaphylaxis in Mice Elizabeth Doyle, Julia Trosien, and Martin Metz Abstract Mouse models of systemic anaphylaxis are important tools for
More informationReproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum
Eur Respir J 2; 16: 242±246 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2 European Respiratory Journal ISSN 93-1936 Reproducibility of measurements of exhaled NO, and cell count and
More informationAsthma is a chronic inflammatory disease. Phosphoinositide 3-kinase d inhibitor suppresses interleukin-17 expression in a murine asthma model
Eur Respir J ; 6: 8 59 DOI:.8/996.669 CopyrightßERS Phosphoinositide -kinase d inhibitor suppresses interleukin-7 expression in a murine asthma model S.J. Park*,", K.S. Lee*,", S.R. Kim*, K.H. Min*, H.
More informationNoninvasive Measurement of Airway Responsiveness in Allergic Mice Using Barometric Plethysmography
Noninvasive Measurement of Airway Responsiveness in Allergic Mice Using Barometric Plethysmography E. HAMELMANN, J. SCHWARZE, K. TAKEDA, A. OSHIBA, G. L. LARSEN, C. G. IRVIN, and E. W. GELFAND Divisions
More informationAsthma: diagnosis and monitoring
Asthma: diagnosis and monitoring NICE guideline: short version Draft for second consultation, July 01 This guideline covers assessing, diagnosing and monitoring suspected or confirmed asthma in adults,
More informationSmall Airways Disease. Respiratory Function In Small Airways And Asthma. Pathophysiologic Changes in the Small Airways of Asthma Patients
Small Airways Disease Respiratory Function In Small Airways And Relevant Questions On Small Airway Involvement In How can small airway disease be defined? What is the link between small airway abnormalities
More informationAdenosine 5 0 -monophosphate increases levels of leukotrienes in breath condensate in asthma
Respiratory Medicine (2004) 98, 651 655 Adenosine 5 0 -monophosphate increases levels of leukotrienes in breath condensate in asthma E. Bucchioni, Z. Csoma, L. Allegra, K.F. Chung, P.J. Barnes, S.A. Kharitonov*
More informationHTRF MEASUREMENT OF CYTOKINE RELEASE FROM FRESH BLOOD SAMPLES
HTRF MEASUREMENT OF CYTOKINE RELEASE FROM FRESH BLOOD SAMPLES APPLICATION NOTE ABSTRACT Cisbio offers a comprehensive line of HTRF cytokine assays to investigate the functional response of immune cells.
More informationSupplementary Figure S1. Flow cytometric analysis of the expression of Thy1 in NH cells. Flow cytometric analysis of the expression of T1/ST2 and
Supplementary Figure S1. Flow cytometric analysis of the expression of Thy1 in NH cells. Flow cytometric analysis of the expression of T1/ST2 and Thy1 in NH cells derived from the lungs of naïve mice.
More informationExpired nitric oxide levels in adult asthmatics
Allergology International (1996) 45: 85-89 Original Article Expired nitric oxide levels in adult asthmatics Chiharu Okada, Akihiko Tamaoki, Yasushi Tanimoto, Ryo Soda and Kiyoshi Takahashi National Sanatorium
More informationInfluence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis
Eur Respir J 1999; 14: 897±901 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 Influence of atopy on exhaled nitric oxide in patients with
More informationHuman CD4+T Cell Care Manual
Human CD4+T Cell Care Manual INSTRUCTION MANUAL ZBM0067.04 SHIPPING CONDITIONS Human CD4+T Cells, cryopreserved Cryopreserved human CD4+T cells are shipped on dry ice and should be stored in liquid nitrogen
More informationCONTENTS. STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1
CONTENTS STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1 ELISA protocol for mite (Dermatophagoides spp.) Group 2 ALLERGENS RESULTS (SUMMARY) TABLE
More information